NASHVILLE, Tennessee – LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Nashville, Tennessee with administrative offices in Boca Raton, Florida, announced the launch of their newly redesigned website at www.lgmpharma.com. This is part of their rebranding initiative and reflects their evolving business strategy to support their clients throughout the entire pathway of drug development while at the same time keeping up with the latest trends of marketing in the 21st century.
“We strived to create a website that would emphasize the key characteristics of the company, including its extensive track record, consultative approach to service and decades of experience in the supply of APIs worldwide,” said Robert Hoppes, LGM Pharma Director for New Business Development.
As a global leader specializing in providing full sourcing options, complete technical capabilities and regulatory support for their products, LGM Pharma recognized the importance of offering a user-friendly and interactive online experience with improved functionality and navigation.
The layout has been optimized for mobile devices, facilitating access through smart phones, laptops and desktops, while on the move. The new design also brings their customers improved search capabilities for the numerous products LGM Pharma supplies.
“We are in such a dynamic business that we needed to have a site that provided our clients and prospects with focused and easily accessible information about our company and its capabilities,” said Steve Sicherman, LGM Pharma Director of Marketing.
“For many years, our customers have trusted us to deliver the technical expertise, superior products and global resources to help them increase the success rates on the projects that are vital to their Companies,” said LGM Pharma Chief of Operations, Mendy Schurder. “Today’s market is rapidly changing and is fraught with shifting global markets, constantly changing regulatory landscapes, pricing pressures, industry consolidation, patent expirations, and increased supply chain complexity. To compete, our customers are looking for more innovative goal oriented solutions and are looking to LGM Pharma to deliver.”
Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity, which is having direct effect on diagnosis or treatment of disease.
The API global market is a highly competitive market hence all the existing players in this market are involved in developing new and advanced therapeutics to maintain their market shares. Currently, market estimates peg the global API market at $121 billion, and expect it to reach nearly $199 billion by 2022 (PharmTech.com March 2, 2016).
About LGM Pharma
LGM Pharma is a leading supplier of active pharmaceutical ingredients (APIs) to Contract manufacturers and various global pharmaceutical firms involved in the manufacturing, research and development of a wide range of therapeutic chemical entities. In its commitment to improving health opportunities all over the world, LGM Pharma has forged partnerships with some of the biggest names in the pharmaceutical industry. Currently, the company supplies over 2,500 active pharmaceutical ingredients to its global clients. For more information, visit www.lgmpharma.com.